top of page
Old Study


Literature References

 Ketamine for Trauma PTSD

Albott CS et al. Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression. J Clin Psychiatry. 2018 May/Jun;79(3).

Feder A et al. Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder, A Randomized Clinical Trial. JAMA Psychiatry. 2014;71(6):681–688.

Selected References Off-Label Use of Ketamine for Depression


  • Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB, Dursun SM. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Ther Adv Psychopharmacol. 2020 May 11;10:2045125320916657. doi: 10.1177/2045125320916657. PMID: 32440333; PMCID: PMC7225830.


  • Grady SE, Marsh TA, Tenhouse A, Klein K. Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature. Ment Health Clin. 2017 Jan;7(1) 16-23.

  • Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci, 11(9), 642-651.

  • Serafini, G. et al. NMDA receptor antagonists for depression: Critical considerations. Ann Clin Psychiatry (2015), 27(3), 213-220.

  • Serafini G, Howland RH, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: a systematic review. Curr Neuropharmacol. 2014;12(5):444-61.

  • Murrough, J. et al. Ketamine for rapid reduction of suicidal ideation: A randomized controlled trial. Psychological Medicine (2015), 45(16), 3571-3580.

bottom of page